ANALYSIS OF REAL-LIFE USE OF IBRUTINIB AFTER RELAPSE TO CONVENTIONAL CHEMOTHERAPY IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKAEMIA

Category Primary study
JournalEuropean Journal of Hospital Pharmacy
Year 2023
This article has no abstract
Epistemonikos ID: ac1b4c3bbf8c4a865be83af851b878554c80d2f3
First added on: Feb 15, 2025